Stable Luminescent [Cu(NN)(PP)]+ Complexes Incorporating a β-Cyclodextrin-Based Diphosphane Ligand with Metal-Confining Properties

A β-cyclodextrin-based diphosphane with metal-confining properties was efficiently synthesized thanks to an unprecedented Smiles-like rearrangement of diphenyl-(2-phosphanylphenyl)phosphane in the presence of excess n-BuLi. The cis-chelating bidentate ligand is capable of forming very stable heteroleptic [Cu(NN)(PP)]⁺ complexes in which a metal-bound diimine ligand (bpy, phen, or mmp) is located within the cyclodextrin cavity. As a result of ligand encapsulation, flattening of the metal tetrahedral geometry in the excited state is disfavored, thereby resulting in enhanced luminescent properties.     

Influence of counterions on the structure of bis(oxazoline)copper(ii) complexes; an EPR and ENDOR investigation

X- and Q-band EPR and ENDOR spectroscopy was used to study the structure of a series of heteroleptic and homoleptic copper bis(oxazoline) complexes, based on the (-)-2,2'-isopropylidenebis[(4S)-4-phenyl-2-oxazoline] ligand and bearing different counterions (chloride versus triflate); labelled [Cu(II)()]. The geometry of the two heteroleptic complexes, [Cu(II)()] and [Cu(II)()], depended on the choice of counterion. Formation of the homoleptic complex was only evident when the Cu(II)(OTf)(2) salt was used (Cu(II)(Cl)(2) inhibited the transformation from heteroleptic to homoleptic complexes). The hyperfine and quadrupole parameters for the surrounding ligand nuclei were determined by ENDOR. Well resolved (19)F and (1)H couplings confirmed the presence of both coordinated water and TfO(-) counterions in [Cu()].     

Correlations and Contrasts in Homo‐ and Heteroleptic Cyclic (Alkyl)(amino)carbene‐Containing Pt0 Complexes

An improved synthetic route to homoleptic complex [Pt(CAAC^Me)₂] (CAAC=cyclic (alkyl)(amino)carbenes) and convenient routes to new heteroleptic complexes of the form [Pt(CAAC^Me)(PR₃)] are presented. Although the homoleptic complex was found to be inert to many reagents, oxidative addition and metal‐only Lewis pair (MOLP) formation was observed from one of the heteroleptic complexes. The spectroscopic, structural, and electrochemical properties of the zero‐valent complexes were explored in concert with density functional theory (DFT) and time‐dependent density functional theory (TD‐DFT) calculations. The homoleptic [Pt(CAAC)₂] and heteroleptic [Pt(CAAC)(PR₃)] complexes were found to be similar in their spectroscopic and structural properties, but their electrochemical behavior and reactivity differ greatly. The unusually strong color of the CAAC‐containing Pt⁰ complexes was investigated by TD‐DFT calculations and attributed to excitations into the LUMOs of the complexes, which are predominantly composed of bonding π interactions between Pt and the CAAC carbon atoms.     

Combining Topological and Steric Constraints for the Preparation of Heteroleptic Copper(I) Complexes

Heteroleptic copper(I) complexes have been prepared from a macrocyclic ligand incorporating a 2,9‐diphenyl‐1,10‐phenanthroline subunit ( M30 ) and two bis‐phosphines, namely bis[(2‐diphenylphosphino)phenyl] ether (POP) and 1,3‐bis(diphenylphosphino)propane (dppp). In both cases, the diphenylphosphino moieties of the PP ligand are too bulky to pass through the 30‐membered ring of M30 during the coordination process, hence the formation of C_2v‐symmetrical pseudo‐rotaxanes is prevented. When POP is used, X‐ray crystal structure analysis shows the formation of a highly distorted [Cu( M30 )(POP)]⁺ complex in which the POP ligand is only partially threaded through the M30 unit. This compound is poorly stable as the Cu^I cation is not in a favorable coordination environment due to steric constraints. By contrast, in the case of dppp, the bis‐phosphine ligand undergoes both steric and topological constraints and adopts a nonchelating coordination mode to generate [Cu₂( M30 )₂(μ‐dppp)](BF₄)₂. This compound exhibits metal‐to‐ligand charge transfer (MLCT) emission characterized by a very large Stokes’ shift (≈200 nm) that is not attributed to a dramatic structural distortion between the ground and the emitting states but to very weak MLCT absorption transitions at longer wavelengths. Accordingly, [Cu₂( M30 )₂(μ‐dppp)](BF₄)₂ shows unusually high luminescence quantum yields for Cu^I complexes, both in solution and in the solid state (0.5 and 7 %, respectively).     

Novel phenanthroline ligands and their kinetically locked copper(I) complexes with unexpected photophysical properties

The new, sterically encumbered phenanthroline ligands 1a,b, both characterized by the presence of bulky aryl substituents (3,5-di-tert-butyl-4-methoxyphenyl, 2,4,6-trimethylphenyl) in the 2,9-position, were prepared along with their homoleptic [Cu(1a,b)2]+ and heteroleptic complexes [Cu(1a,b)(phen)]+ (phen = parent 1,10-phenanthroline). Due to the pronounced steric shielding, particularly effective in ligand 1a, the formation of the homoleptic complex [Cu(1a)2]+ becomes very slow (5 days). Once formed, the homoleptic complexes [Cu(1a,b)2]+ do not exchange ligands even with phen added in excess because they are kinetically locked due to the large tert-butylphenyl substituents at the phenanthroline unit. The electronic absorption spectra of the homoleptic complexes [Cu(1a)2]+ and [Cu(1b)2]+ evidence a strongly different ground state geometry of the two compounds, the former being substantially more distorted. This trend is also observed in the excited-state geometry, as derived by emission spectra and lifetimes in CH2Cl2 solution. The less distorted [Cu(1b)2]+, compared to [Cu(1a)2]+, is characterized by a 15- and over 100-fold stronger emission at 298 and 77 K, respectively. Noticeably, the excited-state lifetime of [Cu(1a)2]+ in solution is unaffected by the presence of molecular oxygen and only slightly shortened in nucleophilic solvents. This unusual behavior supports the idea of a complex characterized by a "locked" coordination environment.     

Stabilities of the Ternary Complexes of Copper(II) with Substituted 1,10-Phenanthrolines and Some Amino Acids in Aqueous Solution

In this study the binary and ternary complexes of copper(II) with substituted 1,10-phenanthrolines [s-phen: 1,10-phenanthroline (phen), 4,7-dimethyl-1,10-phenanthroline (dmphen) and 5-nitro-1,10-phenanthroline (nphen)] and l-amino acids [aa: l-phenylalanine (phe), l-tyrosine (tyr) and l-tryptophan (trp)] have been investigated using potentiometric methods in 0.1 mol·L^?1 KCl aqueous ionic media at 298.2 K. The protonation constants of the ligands and the stability constants of the binary and ternary complexes of Cu(II) with the ligands were calculated from the potentiometric data using the “BEST” software package. It was inferred that the aromatic 1,10-phenanthrolines act as a primary ligand in the ternary complexes, while the oxygen and nitrogen donor-containing amino acids are secondary ligands. The observed values of Δlog₁₀ K indicate that the ternary complexes are more stable than the binary ones, suggesting no interaction takes place between the ligands in the ternary complexes. The magnitudes of the measured stability constants of all of the ternary complexes are in the order [Cu(s-phen)(trp)]⁺ > [Cu(s-phen)(tyr)]⁺ > [Cu(s-phen)(phe)]⁺, which is identical to the sequence found for the binary complexes of Cu(II) with the amino acids. When the substituted 1,10-phenanthroline is changed, the stability constants of the ternary complexes decrease in the following order: [Cu(dmphen)(aa)]⁺ > [Cu(phen)(aa)]⁺ > [Cu(nphen)(aa)]⁺.     

New heteroleptic bis-phenanthroline copper(I) complexes with dipyridophenazine or imidazole fused phenanthroline ligands: spectral, electrochemical, and quantum chemical studies

Two new sterically challenged diimine ligands L(1) (2,9-dimesityl-2-(4'-bromophenyl)imidazo[4,5-f][1,10]phenanthroline) and L(2) (3,6-di-n-butyl-11-bromodipyrido[3,2-a:2',3'-c]phenazine) have been synthesized with the aim to build original heteroleptic copper(I) complexes, following the HETPHEN concept developed by Schmittel and co-workers. The structure of L(1) is based on a phen-imidazole molecular core, derivatized by two highly bulky mesityl groups in positions 2 and 9 of the phenanthroline cavity, preventing the formation of a homoleptic species, while L(2) is a dppz derivative, bearing n-butyl chains in α positions of the chelating nitrogen atoms. The unambiguous formation of six novel heteroleptic copper(I) complexes based on L(1), L(2), and complementary matching ligands (2,9-R(2)-1,10-phenanthroline, with R = H, methyl, n-butyl or mesityl) has been evidenced, and the resulting compounds were fully characterized. The electronic absorption spectra of all complexes fits well with DFT calculations allowing the assignment of the main transitions. The characteristics of the emissive excited state were investigated in different solvents using time-resolved single photon counting and transient absorption spectroscopy. The complexes with ligand L(2), bearing a characteristic dppz moiety, exhibit a very low energy excited-state which mainly leads to fast nonradiative relaxation, whereas the emission lifetime is higher for those containing the bulky ligand L(1). For example, a luminescence quantum yield of about 3 × 10(-4) is obtained with a decay time of about 50 ns for C2 ([Cu(I)(nBu-phen)(L(1))](+)) with a weak influence of strong coordinating solvent on the luminescence properties. Overall, the spectral features are those expected for a highly constrained coordination cage. Yet, the complexes are stable in solution, partly due to the beneficial π stacking between mesityl groups and vicinal phenanthroline aromatic rings, as evidenced by the X-ray structure of complex C3 ([Cu(I)(Mes-phen)(L(2))](+)). Electrochemistry of the copper(I) complexes revealed reversible anodic behavior, corresponding to a copper(I) to copper(II) transition. The half wave potentials increase with the steric bulk at the level of the copper(I) ion, reaching a value as high as 1 V vs SCE, with the assistance of ligand induced electronic effects. L(1) and L(2) are further end-capped by a bromo functionality. A Suzuki cross-coupling reaction was directly performed on the complexes, in spite of the handicapping lability of copper(I)-phenanthroline complexes.     

The gas‐phase ligand exchange of copper and nickel acetylacetonate,hexafluoroacetylacetonate and trifluorotrimethylacetylacetonate complexes

The gas‐phase ligand‐exchange reactions between Cu(II) and Ni(II) complexes containing the acetylacetonate (acac), hexafluoroacetylacetonate (hfac), and trifluorotrimethylacetylacetonate (tftm) ligands were investigated using a triple quadrupole mass spectrometer. The gas‐phase mixed‐ligand products of [Cu(acac)(tftm)]⁺, [Ni(acac)(tftm)]⁺, [Cu(hfac)(tftm)]⁺, and [Ni(hfac)(tftm)]⁺ were formed following the co‐sublimation of either homo‐metal or hetero‐metal precursors. The gas‐phase formation of [Cu(acac)(tftm)]⁺, [Cu(hfac)(tftm)]⁺, [Ni(acac)(tftm)]⁺, and [Ni(hfac)(tftm)]⁺ complexes is reported herein for the first time. The corresponding fragmentation patterns of these species along with those of Cu(tftm)₂ and Ni(tftm)₂ are also presented. Mass‐selected ion‐neutral reactions were investigated. Copyright © 2009 John Wiley & Sons, Ltd.     

亚铜配合物的光致发光与电致发光研究

亚铜[Cu（Ⅰ）]配合物因其低廉的价格、多样化的结构和独特的光物理性质一直备受关注.本文综述了常见磷光Cu（Ⅰ）配合物[Cu（NN）2]＋、[Cu（NN）（PP）]＋和（CuX）mLn（其中NN表示双齿二胺配体,PP表示二膦配体,X表示卤素,L表示含N或P配体）的光致发光与电致发光研究,揭示配合物结构与光学性质的关系,探讨近年来Cu（I）配合物在有机发光二极管（OLED）领域的应用研究新进展.     

Heteroscorpionate‐based heteroleptic copper(II) complexes: Antioxidant,molecular docking and in vitro cytotoxicity studies

Three new heteroscorpionate ligands, (2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL¹), (4‐diethylamino‐2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL²) and (5‐bromo‐2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL³), and their heteroleptic copper(II) complexes of the type [Cu(L^1–3)diimine]ClO₄ ( 1 – 6 ; where diimine =2,2′‐bipyridyl or 1,10‐phenanthroline) have been synthesized and characterized using spectroscopic methods. The molecular structure of ligand HL¹ was determined by single‐crystal X‐ray diffraction. UV–visible, electron paramagnetic resonance and theoretical studies suggest a distorted square pyramidal geometry around copper(II) ion. Analyses of highest occupied and lowest unoccupied molecular orbitals have been used to explain the charge transfer taking place within the complexes. The antioxidant activities of the heteroscorpionate ligands and their heteroleptic copper(II) complexes were determined using ABTS, DPPH and H₂O₂ free radical scavenging assays with respect to standard antioxidant ascorbic acid. In molecular docking studies, the complexes showed π–π, hydrogen bonding, van der Waals and electrostatic interactions with fibroblast growth factor receptor kinase. In vitro cytotoxicity activities of ligands and copper(II) complexes were examined on human breast adenocarcinoma (MCF‐7), cervical (HeLa) and lung (A549) cancer cell lines and normal human dermal fibroblast cell line using MTT assay. Complex 4 exhibited higher anticancer activity than the other complexes against all three cancer lines, being more potent than the standard drug cisplatin.     

Triphenylamine-substituted 2-pyridyl-1,2,3-triazole copper(I) complexes: an experimental and computational investigation

Abstract

Four new heteroleptic copper(I) complexes bearing either 2-pyridyl-1,2,3-triazole (pytri) or the related triphenylamine (TPA) substituted (TPA-tripy) ligands and the ancillary ligands 6,6′-dimesityl-2,2′-bipyridine (diMesbpy) or bis[(2-diphenylphosphino)phenyl] ether (POP) were synthesized in good yields (75-95%). All the complexes were extensively characterized using nuclear magnetic resonance (NMR) spectroscopies and electrospray ionization mass spectrometry (ESIMS) and in the case of the two pytri compounds the solid state structures were determined via X-ray crystallography. The pytri complexes showed MLCT absorption bands which shift from 433?nm for the diMesbpy complex to 347?nm for POP. TPA-pytri complexes introduce an ILCT band resulting in improved visible absorption (376?nm, 26,400 M^?1 cm^?1 for [Cu(TPA-pytri)(diMesbpy)](PF₆)). Emission from this ILCT state (470?nm, Φ?=?0.08) was red-shifted compared to the free ligand with negligible effects from ancillary ligands. Band assignments were confirmed with resonance Raman spectroscopy and TD-DFT calculations.     

From homoleptic to heteroleptic double stranded Copper(I) helicates: the role of self-recognition in self-assembly processes

The ligands 2,9-bis[(6-methyl-2, 2'-bipyridin-6'-yl)methyleneoxymethylenyl]-1,10-phenanthroline (6), 6' ',6' "-bis[(6-methyl-2, 2'-bipyridin-6'-yl)methyleneoxymethylenyl)]-2' ',2' "-bipyridine (2), 5,5'-bis[(6-methyl-2,2'-bipyridin-6'yl)methyleneoxymethylenyl]-2, 2'-bithiophene (7), and 6,6'-bis[(6-methyl-2, 2'-bipyridin-6'-yl)methyleneoxymethylenyl]-2,2'-biphenyl (8) and their respective homo- and heteroleptic double-stranded copper(I) complexes were prepared and characterized in order to estimate the importance of self-recognition in the self-assembly processes of double-stranded copper complexes. The homoleptic double-stranded copper complexes of 2, 6, 7, and 8 were characterized by NMR, FAB-MS, and electrochemistry. It was found that 6 and 2 each form a single double-stranded helicate having the structure of [(L)(2)Cu(3)](3+) (L = 2 or 6), 7 forms two double-stranded [(7)(2)Cu(3)](3+) complexes, and 8 results in a mixture of at least two [(8)(2)Cu(2)](2+) complexes. The potential shift, DeltaE degrees (,) of the Cu(+)/Cu(2+) redox process of these complexes reflects the binding affinity of the different binding sites to the copper cation. The electrochemical data show that the central units have a higher affinity to Cu(+) as compared to the off-center binding sites. NMR was used to determine the actual complex composition obtained from different mixtures of 2, 6, or 7 with Cu(+). Interestingly, we have found that, although 6, 2, and 7 each form homoleptic double-stranded complexes, no heteroleptic double-stranded copper complexes were formed from the mixtures of 7 with either 6 or 2. However, when mixtures of 6 and 2 are used, helicate distributions seem to follow simple statistics. These results are discussed in terms of the relative importance of self-recognition in the self-assembly of double-stranded helicates.     

Influence of Peripheral Substitution on the Magnetic Behavior of Single‐Ion Magnets Based on Homo‐ and Heteroleptic TbIII Bis(phthalocyaninate)

A series of homoleptic ([Tb^III(Pc)₂]) and heteroleptic ([Tb^III(Pc)(Pc′)]) Tb^III bis(phthalocyaninate) complexes that contain different peripheral substitution patterns (i.e., tert‐butyl or tert‐butylphenoxy groups) have been synthesized in their neutral radical forms and then reduced into their corresponding anionic forms as stable tetramethylammonium/tetrabutylammonium salts. All of these compounds were spectroscopically characterized and their magnetic susceptibility properties were investigated. As a general trend, the radical forms exhibited larger energy barriers for spin reversal than their corresponding reduced compounds. Remarkably, heteroleptic complexes that contain electron‐donor moieties on one of the two Pc ligands show higher effective barriers and blocking temperatures than their homoleptic derivatives. This result is assigned to the elongation of the N? Tb distances in the substituted macrocycle, which brings the terbium(III) ion closer to the unsubstituted Pc, thus enhancing the ligand‐field effect. In particular, heteroleptic [Tb^III(Pc)(Pc′)] complex 4 , which contains one octa(tert‐butylphenoxy)‐substituted Pc ring and one bare Pc ring, exhibits the highest effective barrier and blocking temperature for a single‐molecule magnet reported to date.     

Mixed-Ligand Complex Formation Equilibria of Copper(II) with 6-Methylpicolinic Acid and Some Amino Acids

In this work, the ternary complex formation among copper(II), 6-methylpicolinic acid (H6Mepic) as primary ligand, and the amino acids aspartic acid (H₂Asp), glutamic acid (H₂Glu) and histidine (HHis) as secondary ligands, were studied in aqueous solution at 25 °C using 1.0 mol·dm^?3 KNO₃ as the ionic medium. Analysis of the potentiometric data using the least squares computational program LETAGROP indicates formation of the species [Cu(6Mepic)]⁺, Cu(6Mepic)(OH), [Cu(6Mepic)(OH)₂]^?, Cu(6Mepic)₂ and [Cu(6Mepic)₃]^? in the binary Cu(II)–H6Mepic system. In the ternary Cu(II)–H6Mepic–H₂Asp system the complexes [Cu(6Mepic)(H₂Asp)]⁺, Cu(6Mepic)(HAsp), [Cu(6Mepic)(Asp)]^? and [Cu(6Mepic)(Asp)(OH)]^2? were observed. In the case of the Cu(II)–H6Mepic–H₂Glu system the complexes Cu(6Mepic)(HGlu), [Cu(6Mepic)(Glu)]^?, [Cu(6Mepic)(Glu)(OH)]^2? and [Cu(6Mepic)(glu)(OH)₂]^3? were detected. Finally, in the Cu(II)–H6Mepic–HHis system the complexes [Cu(6Mepic)(HHis)]⁺, Cu(6Mepic)(His) and [Cu(6Mepic)(His)(OH)]^? were observed. The species distribution diagrams as a function of pH are briefly discussed.     

Syntheses,Structures and Anticancer Activity of NNO‐Tridentate Schiff Base Copper(II) Complexes

A series of heteroleptic copper(II) complexes [Cu( ^R QYMP )(Py]] ( 1a ‐ 4d ) supported on NNO‐tridentate Schiff base ( ^R QYMP ‐H) and bipyridine (Py=bpy, a ; phen, b ; dpq, c ; dppz, d ) co‐ligands have been synthesized and characterized. X‐ray crystal structural studies of complexes 1b , 2c , 3d and 4a displays that these complexes are mononuclear with a distorted square pyramidal geometry around the copper center. Cytotoxicity results indicate that all of these complexes have much higher activity against HeLa, SCC15, BCC and Ca9‐22 cancer cell lines as compared to cisplatin. Further, copper complex bearing suitable bulky group Schiff base ligands with dppz co‐ligand could be considered in designing efficient metalbased anticancer agents.     

Terpyridine Based Heteroleptic Ruthenium Complexes: Influence of Donor and Acceptor Ligands in Photosensitization

We report heteroleptic ruthenium complexes of terpyridine (tpy) ligands with directly linked carboxylic acid anchors. These complexes feature methyl or methoxy-substituted ^4′−Phtpy as donor ligands. We prepared these heteroleptic complexes from the ruthenium (II) precursor via a milder route to preclude the homoleptic complex formation. The donor−acceptor arrangement of tpy ligands in these ruthenium complexes renders visible light absorption giving metal and ligand-to-ligand charge transfer excitations at c.a. 490 nm. We evaluate the effect of the tpy donor substituents on the light-harvesting ability in Dye-Sensitized Solar Cells (DSSCs) and compare their photosensitizing ability with heteroleptic complexes bearing phenyl spacer at the acceptor end. Further, scrutinizing their photovoltaic performance, we studied their electron transfer kinetics in DSSCs using electrochemical impedance spectroscopy. This paper presents the structure-photosensitization relationship of these heteroleptic ruthenium complexes through a combined experimental and computational approach.     

Photochemistry of RuII 4,4′‐Bi‐1,2,3‐triazolyl (btz) Complexes: Crystallographic Characterization of the Photoreactive Ligand‐Loss Intermediate trans‐[Ru(bpy)(κ2‐btz)(κ1‐btz)(NCMe)]2+

We report the unprecedented observation and unequivocal crystallographic characterization of the meta‐stable ligand loss intermediate solvento complex trans‐[Ru(bpy)(κ²‐btz)(κ¹‐btz)(NCMe)]²⁺ ( 1 a ) that contains a monodentate chelate ligand. This and analogous complexes can be observed during the photolysis reactions of a family of complexes of the form [Ru($\widehat{NN}$ )(btz)₂]²⁺ ( 1 a – d : btz=1,1′‐dibenzyl‐4,4′‐bi‐1,2,3‐triazolyl; $\widehat{NN}$ =a) 2,2′‐bipyridyl (bpy), b) 4,4′‐dimethyl‐2,2′‐bipyridyl (dmbpy), c) 4,4′‐dimethoxy‐2,2′‐bipyridyl (dmeobpy), d) 1,10‐phenanthroline (phen)). In acetonitrile solutions, 1 a – d eventually convert to the bis‐solvento complexes trans‐[Ru($\widehat{NN}$ )(btz)(NCMe)₂]²⁺ ( 3 a – d ) along with one equivalent of free btz, in a process in which the remaining coordinated bidentate ligands undergo a new rearrangement such that they become coplanar. X‐ray crystal structure of 3 a and 3 d confirmed the co‐planar arrangement of the $\widehat{NN}$ and btz ligands and the trans coordination of two solvent molecules. These conversions proceed via the observed intermediate complexes 2 a – d , which are formed quantitatively from 1 a – d in a matter of minutes and to which they slowly revert back on being left to stand in the dark over several days. The remarkably long lifetime of the intermediate complexes (>12 h at 40 °C) allowed the isolation of 2 a in the solid state, and the complex to be crystallographically characterized. Similarly to the structures adopted by complexes 3 a and d , the bpy and κ²‐btz ligands in 2 a coordinate in a square‐planar fashion with the second monodentate btz ligand coordinated trans to an acetonitrile ligand.     

Antiproliferative Homoleptic and Heteroleptic Phosphino Silver(I) Complexes: Effect of Ligand Combination on Their Biological Mechanism of Action

A series of neutral mixed-ligand [HB(pz)₃]Ag(PR₃) silver(I) complexes (PR₃ = tertiary phosphine, [HB(pz)₃]⁻ = tris(pyrazolyl)borate anion), and the corresponding homoleptic [Ag(PR₃)₄]BF₄ compounds have been synthesized and fully characterized. Silver compounds were screened for their antiproliferative activities against a wide panel of human cancer cells derived from solid tumors and endowed with different platinum drug sensitivity. Mixed-ligand complexes were generally more effective than the corresponding homoleptic derivatives, but the most active compounds were [HB(pz)₃]Ag(PPh₃) (5) and [Ag(PPh₃)₄]BF₄ (10), both comprising the lipophilic PPh₃ phosphine ligand. Detailed mechanistic studies revealed that both homoleptic and heteroleptic silver complexes strongly and selectively inhibit the selenoenzyme thioredoxin reductase both as isolated enzyme and in human ovarian cancer cells (half inhibition concentration values in the nanomolar range) causing the disruption of cellular thiol-redox homeostasis, and leading to apoptotic cell death. Moreover, for heteroleptic Ag(I) derivatives, an additional ability to damage nuclear DNA has been detected. These results confirm the importance of the type of silver ion coordinating ligands in affecting the biological behavior of the overall corresponding silver complexes, besides in terms of hydrophilic–lipophilic balance, also in terms of biological mechanism of action, such as interaction with DNA and/or thioredoxin reductase.     

Dicopper(II) complexes of a new pyrazolate-containing Schiff-base macrocycle and related acyclic ligand

Dicopper(II) complexes of two new 3,5-disubstituted-pyrazole-based ligands, bis(quadridentate) macrocyclic ligand (L1)(2-) and bis(terdentate) acyclic ligand (L2)(-), were synthesised by Schiff base condensation of 3,5-diformylpyrazole and either one equivalent of 1,3-diaminopropane or two equivalents of 2-(2-aminoethyl)pyridine in the presence of one or two equivalents of copper(II) ions, respectively. Copper(II) acetate monohydrate was employed in the synthesis of [Cu(2)(L1)(OAc)(2)], [Cu(2)(L2)(H(2)O)(2)(OAc)(3)] and [Cu(II)(2)(L1)(NCS)(2)]; in the last of these one equivalent of NaNCS per copper(II) ion was also added. The fourth complex, [Cu(2)(L2)(NCS)(2)(DMF)]BF(4), was prepared using copper(II) tetrafluoroborate hexahydrate, along with two equivalents of NaOH and six of NaSCN. All four of these dimetallic complexes have been characterised by single crystal X-ray diffraction: the two macrocyclic complexes are the first such Schiff base complexes to be so characterised. A feature common to all four of the structures is bridging of the two copper(II) centres by the pyrazolate moiety/moieties. The structure determinations show that the coordination mode of the acetate groups in both [Cu(2)(L1)(OAc)(2)].2MeOH.H(2)O and [Cu(2)(L2)(H(2)O)(2)(OAc)(3)] is unidentate as had been tentatively predicted by analysis of the infrared spectra (DeltaOCO of 199 and 208 cm(-1), respectively). The magnetochemical studies of the macrocyclic complexes, over the temperature range 4-300 K, revealed strong antiferromagnetic coupling with J = -169 and -213 cm(-1) for [Cu(2)(L1)(OAc)(2)].2H(2)O and [Cu(II)(2)(L1)(NCS)(2)].DMF respectively. The J values have been discussed in relation to a published correlation involving the CuN(pyrazolate)N(pyrazolate) angles.     

Iridium(III) Complexes with [−2, −1, 0] Charged Ligand Realized Deep-Red/Near-Infrared Phosphorescent Emission

A series of [−2, −1, 0] charged-ligand based iridium(III) complexes of [Ir(bph)(bpy)(acac)] ( 1 ), [Ir(bph)(2MeO-bpy)(acac)] ( 2 ), [Ir(bph)(2CF₃-bpy)(acac)] ( 3 ), [Ir(bph)(bpy)(2^tBu-acac)] ( 4 ) and [Ir(bph)(bpy)(CF₃-acac)] ( 5 ), which using biphenyl as dianionic ligand [−2], acetylacetone (or its derivatives) as monoanionic ligand [−1], and 2,2′-bipyridine (or its derivatives) as neutral ligand [0] were designed and synthesized. The chemical structures were well characterized. All of the ligands have simple chemical structures, thus further making the complexes have excellent thermal stability and are easy to sublimate and purify. Phosphorescent characteristics with short emission lifetime were demonstrated for these emitters. Notably, all of the complexes exhibit remarkable deep red/near infrared emission, which is quite different from the reported [−1, −1, −1] charged-ligand based iridium(III) complexes. The photophysical properties of these complexes are regularly improved by introducing electron-donating or -withdrawing groups into [−1] or [0] charged-ligand. The related organic light-emitting diodes exhibited deep red/near infrared emission with acceptable external quantum efficiency and low turn-on voltage (<2.6 V). This work provides a new idea for the construction of new type phosphorescent iridium(III) emitters with different valence states of [−2, −1, 0] charged ligands, thus offering new opportunities and challenges for their optoelectronic applications.